Pépin, D., Sosulski, A., Zhang, L., Wang, D., Vathipadiekal, V., Hendren, K., . . . Donahoe, P. K. (2015). AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer. Proc Natl Acad Sci U S A.
Styl ChicagoPépin, David, et al. "AAV9 Delivering a Modified Human Mullerian Inhibiting Substance As a Gene Therapy in Patient-derived Xenografts of Ovarian Cancer." Proc Natl Acad Sci U S A 2015.
Citace podle MLAPépin, David, et al. "AAV9 Delivering a Modified Human Mullerian Inhibiting Substance As a Gene Therapy in Patient-derived Xenografts of Ovarian Cancer." Proc Natl Acad Sci U S A 2015.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..